SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing heavy trading volume as investors debate its ability to convert significant AI and data-center capital expenditures into sustainable cash flow. While some traders view recent price action as a technical bottoming and a potential asymmetric buying opportunity, others remain cautious due to concerns over high debt levels and the broader sell-off impacting the software sector.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending as market participants weigh its depressed valuation and aggressive share buybacks against ongoing concerns regarding branded checkout growth and leadership silence. Investors are heavily debating the stock's potential for a significant re-rating, with active community discussions centering on prospective buyout rumors, new partnership integrations, and speculation about strategic pivots under the new CEO.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a historic rally driven by significant new partnerships with tech giants like Google and SpaceX, alongside government-backed initiatives, leading to intense debate over whether the stock is a long-term growth play or an overextended momentum trap. The community is actively discussing the stock's parabolic climb toward all-time highs, with intense speculation on potential pullbacks, earnings expectations, and the impact of geopolitical developments on chip supply chains.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is surging toward record highs, driven by its upcoming inclusion in the Nasdaq-100 and relentless demand for high-performance memory chips in AI data centers. While the community remains divided between those expecting further gains and others warning of an "AI bubble," market participants are heavily focused on the index rebalance and potential volatility from geopolitical tensions.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is currently trending due to a major breakthrough, securing over $4 million in U.S. government contracts to advance its semiconductor platform for quantum and high-speed data communications. The community is actively discussing this news as a significant validation of the company's proprietary technology, with many investors debating the long-term potential for commercial scaling, sector-wide impact, and the stock's future trajectory following recent market volatility.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. (ASST) is trending as investors debate the company's aggressive Bitcoin treasury strategy and the potential impact of its proposed T-Strive Digital Credit ETF (DGCR). While community sentiment remains highly polarized, many traders are actively discussing the stock's high volatility and its correlation to Bitcoin's price action, with some viewing recent pullbacks as accumulation opportunities ahead of a potential recovery.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as investors show renewed enthusiasm for its pivot toward AI-integrated network infrastructure and optical solutions, bolstered by strategic partnerships with major tech players. The community is actively discussing bullish institutional accumulation and key contract wins, with many highlighting the stock as a long-term play in the 6G and data center hardware space.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is currently experiencing high volatility driven by conflicting geopolitical headlines, specifically regarding the ongoing Iran blockade and China's recent public statement warning the U.S. against interfering with its transit through the Strait of Hormuz. Market participants remain deeply polarized, with many retail traders actively discussing whether the current price action is a genuine response to international tensions or an elaborate manipulation tactic aimed at trapping bears and retail investors.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing extreme volatility and massive short liquidations, driving the token to record highs amid intense community debate over whether it is a legitimate high-growth asset or a speculative pump-and-dump scheme. Investors are actively discussing the project's web3 music event utility and upcoming partnership rumors while expressing deep caution over the high concentration of holdings and the potential for a sharp correction.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors digest the FDA's decision to award a National Priority Voucher to its lead oncology candidate, daraxonrasib, while the community intensely debates its competitive positioning against other RAS-targeting peers in the pancreatic cancer space. Discussions are heavily focused on the drug's transformational Phase 3 clinical data, with analysts frequently raising price targets as expectations mount for a major commercial launch and long-term M&A potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tudor Investment Corp ET AL Invests $1.43 Million in Supernus Pharmaceuticals, Inc. $SUPN

Tudor Investment Corp ET AL bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with...

Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $1,001 and $15,000 in Supernus Pharmaceuticals stock on March 3rd. T...

Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Cross Above 200-Day Moving Average - Should You Sell?

Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Cross Above 200-Day Moving Average - Should You Sell...

Aberdeen Group plc Acquires New Shares in Supernus Pharmaceuticals, Inc. $SUPN

Aberdeen Group plc acquired a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the...

Hennion & Walsh Asset Management Inc. Has $4.01 Million Position in Supernus Pharmaceuticals, Inc. $SUPN

Hennion & Walsh Asset Management Inc. lessened its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 20.7% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 80,651 shares of the specialty pharmaceutical company's stock aft...

Supernus Pharmaceuticals, Inc. $SUPN Stock Holdings Lowered by JPMorgan Chase & Co.

JPMorgan Chase & Co. trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) by 45.6% in the third quarter, according to its most recent Form 13F filing with the...

Tudor Investment Corp ET AL Makes New Investment in Supernus Pharmaceuticals, Inc. $SUPN

Tudor Investment Corp ET AL bought a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Free Report) in the third quarter, according to its most recent filing with the Securities...

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Given Consensus Rating of "Hold" by Analysts

Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven ratings firms that are covering the firm, MarketBeat...

Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Pass Above 200-Day Moving Average   - What's Next?

Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Crosses Above 200-Day Moving Average - Should You Sell...

Supernus Pharmaceuticals (NASDAQ:SUPN) VP Sells $2,514,000.00 in Stock

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN - Get Free Report) VP Padmanabh Bhatt sold 50,000 shares of Supernus Pharmaceuticals stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $50.28, for a total transaction of $2,514,000.00. Following the...

Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.

Supernus Pharmaceuticals Inc

Start of a real move higher

Dead cat - we retest the lows

Show me the results

Software is bouncing hard today. Is this the start of a sustained recovery or just a dead cat bounce before we retest the lows?

SUPN
Supernus Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SUPN News

SUPNSupernus Pharmaceuticals Inc